DeepMed Research

MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Ketamine in Colorectal Surgery

Phase 4

Withdrawn

Conditions: Pain, Postoperative
Acute Pain
Colorectal Surgery

Interventions: Drug: Placebo
Drug: Ketamine
Drug: Acetaminophen
Drug: Opioid
Drug: Alvimopan

First Posted Date: 2016-05-27

Last Posted Date: 2017-10-26

Lead Sponsor: Medical College of Wisconsin

Registration Number: NCT02785003

Locations: 🇺🇸
Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States

Evaluating the Effects of Genetic Testing on Patients' Stress Levels

Active, not recruiting

Conditions: Breast Cancer

Interventions: Other: Questionnaires to Evaluate Anxiety Related to Genetic Testing

First Posted Date: 2016-05-26

Last Posted Date: 2023-10-17

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 164

Registration Number: NCT02783664

Locations: 🇺🇸
Froedtert Hospital, Milwaukee, Wisconsin, United States

Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer

Phase 2

Completed

Conditions: Resectable Pancreatic Cancer

Interventions: Drug: Doxycycline

First Posted Date: 2016-05-18

Last Posted Date: 2023-07-03

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 12

Registration Number: NCT02775695

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Gastroschisis Outcomes of Delivery (GOOD) Study

Not Applicable

Recruiting

Conditions: Gastroschisis

Interventions: Other: 38-week delivery
Other: 35-week delivery

First Posted Date: 2016-05-17

Last Posted Date: 2025-03-13

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 800

Registration Number: NCT02774746

Locations: 🇺🇸
University of Wisconsin - Madison, Madison, Wisconsin, United States
🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸
Loma Linda University Children's Hospital, Loma Linda, California, United States

and more 34 locations

Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer

Phase 2

Completed

Conditions: Ovarian Cancer

Interventions: Drug: Pembrolizumab
Drug: Carboplatin
Drug: Paclitaxel

First Posted Date: 2016-05-10

Last Posted Date: 2024-02-26

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 29

Registration Number: NCT02766582

Locations: 🇺🇸
Medical College of Wisconsin and Froedtert Hospital, Milwaukee, Wisconsin, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

Phase 2

Completed

Conditions: Sickle Cell Disease

Interventions: Procedure: Standard of Care
Drug: Busulfan
Drug: Fludarabine
Drug: r-ATG
Procedure: Hematopoietic Cell Transplant
Drug: Tacrolimus
Drug: Methotrexate
Drug: Alemtuzumab
Drug: Total Body Irradiation (TBI)
Drug: Sirolimus
Drug: Melphalan
Drug: G-CSF

First Posted Date: 2016-05-09

Last Posted Date: 2025-04-18

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 138

Registration Number: NCT02766465

Locations: 🇺🇸
Dana Farber Cancer Institute/Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Boston University, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute/Massachusetts General Hospital, Boston, Massachusetts, United States

and more 32 locations

MRI-Based Preoperative Accelerated Partial Breast Irradiation

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Radiation: Phase II - Preoperative Radiation followed by Lumpectomy.

First Posted Date: 2016-04-05

Last Posted Date: 2025-01-22

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 39

Registration Number: NCT02728076

Locations: 🇺🇸
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Hyperglycemia and Mitochondrial Function in The Endothelium of Humans

Completed

Conditions: Diabetes
Hyperglycemia

Interventions: Other: 75 g glucose solution

First Posted Date: 2016-02-15

Last Posted Date: 2025-01-10

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 35

Registration Number: NCT02682342

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

Phase 1

Withdrawn

Conditions: Scleroderma

Interventions: Drug: Calcipotriene
Drug: Clobetasol
Drug: Tacrolimus

First Posted Date: 2016-02-11

Last Posted Date: 2018-07-18

Lead Sponsor: Medical College of Wisconsin

Registration Number: NCT02680717

Loop Duodenal Switch Surgery in Morbidly Obese Patients

Terminated

Conditions: Obesity
Type-2 Diabetes Mellitus

First Posted Date: 2016-02-02

Last Posted Date: 2016-07-07

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 1

Registration Number: NCT02671331

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy